Thursday, September 18, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

MicroStrategy’s Bitcoin Bet Intensifies as Index Exclusion Looms

Robert Sasse by Robert Sasse
September 15, 2025
in Analysis, Bitcoin, Crypto Stocks, S&P 500
0
Strategy Stock
0
SHARES
19
VIEWS
Share on FacebookShare on Twitter

MicroStrategy continues to double down on its monumental cryptocurrency position, reinforcing its status as the world’s largest corporate holder of Bitcoin. However, this aggressive accumulation strategy comes at a cost, as the company faces continued exclusion from the prestigious S&P 500 index despite meeting formal eligibility requirements.

Persistent Bitcoin Acquisition

The business intelligence firm executed another significant purchase between September 2nd and 7th, acquiring 1,955 Bitcoin at a total cost of $217.4 million. This latest investment brought the average purchase price to approximately $111,196 per coin.

MicroStrategy’s treasury now holds an unprecedented 638,460 Bitcoin, valued at roughly $71 billion at current market prices. The company’s total investment in cryptocurrency amounts to approximately $47.2 billion, reflecting an average acquisition cost of $73,880 per Bitcoin. These recent purchases were funded through the sale of corporate stock and convertible notes.

Index Committee Rejection

In a move that surprised market observers, the S&P 500 index committee declined to include MicroStrategy in its benchmark index during the September rebalancing period. This decision came despite the company meeting the necessary market capitalization thresholds and reporting positive quarterly earnings.

The exclusion appears rooted in concerns over the extreme volatility of MicroStrategy’s earnings, which directly correlate with Bitcoin price fluctuations. The S&P 500 traditionally favors companies with diversified revenue streams and stable financial performance. This rejection denies MicroStrategy access to substantial passive investment flows from index funds and ETFs that automatically track the benchmark index.

Should investors sell immediately? Or is it worth buying Strategy?

Leadership Defends Strategy

Executive Chairman Michael Saylor remains undeterred, presenting compelling performance metrics to justify the company’s approach. According to Saylor, MicroStrategy’s Bitcoin strategy has generated an annualized return of 91 percent, significantly outperforming notable tech giants. By comparison, Nvidia has achieved 72 percent while Tesla posted 32 percent over the same period.

With capital costs of 14 percent and Bitcoin returns of 55 percent, the company’s leadership maintains that their mathematical model supports continued accumulation.

Technical Pressures Mount

Despite impressive theoretical returns, MicroStrategy shares face significant technical headwinds. The stock currently trades below key technical indicators and maintains a clear downward trajectory.

Equity researchers at TD Cowen maintained their “Buy” recommendation but reduced their price target from $680 to $640, acknowledging the persistent volatility concerns. The company’s extreme concentration in Bitcoin remains the primary risk factor for investors considering the stock.

Ad

Strategy Stock: Buy or Sell?! New Strategy Analysis from September 18 delivers the answer:

The latest Strategy figures speak for themselves: Urgent action needed for Strategy investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from September 18.

Strategy: Buy or sell? Read more here...

Tags: Strategy
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

Armour Residential Reit Stock
Analysis

Armour Residential REIT Navigates Market Volatility Amid Dividend Consistency

September 18, 2025
Incyte Stock
Analysis

Incyte’s Pipeline Receives Major Boost from Promising Dermatology Drug

September 18, 2025
Nuscale Power Stock
Analysis

Nuscale Power Stock: Record Deal Meets Profitability Concerns

September 18, 2025
Next Post
Bruker Stock

Bruker Faces Investor Backlash After Surprise Equity Offering

Chevron Stock

Chevron Navigates Strategic Overhaul Amid Divergent Investor Views

Enphase Energy Stock

Enphase Energy Faces S&P 500 Removal in Major Index Shakeup

Recommended

Warren Woods Public Schools Partners with Ameresco for Sustainable Energy Upgrades

2 years ago
EPAC stock news

Strs Ohio Reduces Stake in Enerpac Tool Group Corp. as Company Exceeds Analyst Expectations

2 years ago
Kraft Heinz Stock

Strategic Reversal: Kraft Heinz Announces Corporate Split to Unlock Value

1 week ago

Analyst at BMO Capital Expresses Positive Sentiment and Increases Price Target for Brinker International

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

AAPL Adobe Alibaba Alphabet Amazon AMD AMZN Apple ASML BA BigBear.ai BioNTech Broadcom Coinbase DIS Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Opendoor Oracle Oxford Lane Capital Palantir Red Cat Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray TSLA Unitedhealth Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Eli Lilly’s Oral Diabetes Candidate Outperforms Rival in Clinical Showdown

Broadcom’s $10 Billion Mystery Client Fuels AI Growth Surge

Adobe’s AI Breakthrough Fails to Impress Investors

Boeing’s Dual Challenge: Innovation Gains Amid Regulatory Setbacks

Yum China Doubles Down on Shareholder Returns Amid Market Volatility

Can a Strategic Alliance Reverse Alight’s Downward Trajectory?

Trending

Armour Residential Reit Stock
Analysis

Armour Residential REIT Navigates Market Volatility Amid Dividend Consistency

by Dieter Jaworski
September 18, 2025
0

While Armour Residential REIT continues its pattern of stable dividend distributions, its stock performance reflects a more...

Incyte Stock

Incyte’s Pipeline Receives Major Boost from Promising Dermatology Drug

September 18, 2025
Nuscale Power Stock

Nuscale Power Stock: Record Deal Meets Profitability Concerns

September 18, 2025
Eli Lilly Stock

Eli Lilly’s Oral Diabetes Candidate Outperforms Rival in Clinical Showdown

September 18, 2025
Broadcom Stock

Broadcom’s $10 Billion Mystery Client Fuels AI Growth Surge

September 18, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Armour Residential REIT Navigates Market Volatility Amid Dividend Consistency
  • Incyte’s Pipeline Receives Major Boost from Promising Dermatology Drug
  • Nuscale Power Stock: Record Deal Meets Profitability Concerns

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com